Secretion of corticotrophin-releasing hormone and arginine vasopressin by the neonatal rat hypothalamus in vitro: Age-dependent maturation of the responses to cytokines and modulation by glucocorticoids and lipocortin 1

Developmental Brain Dysfunction

Volumn 10, Issue 6, 1997, Pages 482-502

  Buckingham, Julia C ^a   Flower, Roderick J ^b   Kikkert, Robert ^a   Loxley, Helen D ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Arginine vasopressin; Corticotrophin releasing hormone; Cytokines; Developmental neurobiology neuroendocrinology; Glucocorticoids; Lipocortin 1 (annexin 1); Neonate

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DEXAMETHASONE SODIUM PHOSPHATE; GLUCOCORTICOID; LIPOCORTIN 1; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 8;

ADOLESCENT; ADRENALECTOMY; AGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; HORMONE RELEASE; HYPOTHALAMUS; IN VITRO STUDY; MALE; NEWBORN; NONHUMAN; ONTOGENY; RAT; REVIEW;

EID: 0031544807     PISSN: 10195815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Schapiro S: Neonatal cortisol administration: Effect on growth, the adrenal gland and pituitary-adrenal response to stress. Proc Soc Exp Biol Med 1965;120:771-774.
2. Seckl JR: 11β-hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action? in Gangong WF, Martini L (eds): Frontiers in Neuroendocrinology. New York, Academic Press, 1997, vol 18, pp 49-99.
3. Rosenfeld P, Suchecki D, Levine S: Multifactorial regulation of the hypothalamic-pituitary-adrenal axis during development. Neurosci Biobehav Rev 1992;16:553-568.
4. Sapolsky RM, Meaney MJ: Maturation of the adrenocortical stress response: Neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 1986;11:65-76.
5. Walker C-D, Penin M, Vale W, Rivier C: Ontogeny of the stress response in the rat: Role of the pituitary and the hypothalamus. Endocrinology 1986;118:1445-1451.
6. Walker C-D: The pituitary-adrenocortical system of neonatal rats is responsive to stress throughout development in a time-dependent and stressor-specific fashion. Endocrinology 1991;128: 1385-1395.
7. Rivier C: Stimulatory effect of interleukin-1β on the hypothalamic-pituitary-adrenal axis of the rat: influence of age, gender and circulating sex steroids. J Endocrinol 1994;140:365-372.
8. O'Grady MP, Hall NRS, Menzies RA: Interleukin-1β stimulates adrenocorticotropin and corticosterone release in 10-day old rat pups. Psychoneuroendocrinology 1993;18:241-247.
9. Levine S, Berkenbosch F, Suchecki D, Tilders NH: Pituitary-adrenal and interleukin-6 responses to recombinant interleukin-1 in neonatal rats. Psychoneuroendocrinology 1994;19:143-153.
10. Kent S, Tom C, Levine S: Effect of interleukin-1β on pituitary-adrenal responses and body weight in neonatal rats: Interaction with maternal deprivation. Stress 1997, in press.
11. Widmaier EP: Changes in responsiveness of the hypothalamic-pituitary-adrenal axis during develoment in rats. Endocrinology 1990;126: 3116-3123.
12. Chautard T: Effect of excitatory amino acid on the hypothalamo-pituitary-adrenal axis in the rat during the stress hyporesponsive period. Neuroendocrinology 1993;57:70-78.
13. Witek-Janusek L: Pituitary-adrenal response to bacterial endotoxin in developing rats. Am J Physiol 1988;255:E525-E530.
14. Kent S, Kernahan S, Levine S: Effects of excitatory amino acids on the hypothalamic-pituitary axis of the neonatal rat. Dev Brain Res 1996;94:1-13.
15. Guillet R, Saffron M, Michaelson SM: Pituitary-adrenal response in neonatal rats. Endocrinology 1980;106:991-994.
16. Walker CD, Sapolsky RM, Meaney UI, Vale VW, Rivier CL: Increased pituitary sensitivity to glucocorticoid feedback during the stress nonresponsive period in the neonatal rat. Endocrinology 1986;119:1816-1821.
17. Walker C-D, Akana SF, Cascio CS, Dallman MF: Adrenalectomy in the neonate: Adult-like adrenocortical system responses to both removal and replacement of corticosterone. Endocrinology 1990; 127:832-842.
18. Koch B, Lutz-Bucher B: The vasopressin receptor system in the neonatal pituitary gland: Evidence for reduced binding capacity and signal transmission. Neuroendocrinology. 1990;51:592-598.
19. Grino M, Scott-Young W III, Burgunder J-M: Ontogeny of expression of the corticotropin-releasing factor gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in rat pituitary. Endocrinology 1989;124:60-68.
20. Hary L, Dupouy JP, Chatelain A: Effect of norepinephrine on the pituitary adrenocorticotrophic activation by either stress and on the in vitro release of ACTH by the adenohypophysis of male and female newborn rats. Neuroendocrinology 1984;39:105-113.
21. Widmaier EP: Glucose homeostasis and hypothalamic-pituitary-adrenocortical axis during development in rats. Am J Physiol 1990;259 (Endocrinol Metab 22):E602-E613.
22. Widmaier EP: Glucose homeostasis and hypothalamic-pituitary-adrenocortical axis during development in rats. Am J Physiol 1990;259 (Endocrinol Metab 22):E602-E613.
23. Buckingham JC, Loxley HD, Christian HC, Philip J: Activation of the hypothalamo-pituitary-adrenocortical axis by immune insults: The roles and interactions of cytokines, eicosanoids and glucocorticoids. Pharmacol Biochem Behav 1996;54: 285-298.
24. Berkenbosch F, van-Oers J, del Ray A, Tilders F, Besedovsky H: Corticotrophin-releasing factor-producing neurones in the rat activated by interleukin-1. Science 1987;238:524-526.
25. Sapolsky R, Rivier C, Yamomoto G, Platsky P, Vale W: Interleukin-1 stimulates the secretion of hypothalamic corticotrophin releasing factor. Science 1987;238:522-524.
26. Loxley HD, Cowell AM, Flower RT, Buckingham JC: Modulation of the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: A role for lipocortin 1 in the feedback inhibition of CRF-41 release? Neuroendocrinology 1993;57:801-814.
27. Tsagariskis S, Gillies GE, Rees LH, Besser GM. Grossman A: Interleukin-1 directly stimulates the release of corticotrophin releasing factor from rat hypothalamus. Neuroendocrinology 1989;49: 98-101.
28. Loxley HD, Cowell AM, Flower RI, Buckingham JC: Effects of lipocortin 1 and dexamethasone on the secretion of corticotrophin-releasing factors in the rat: In vitro and in vivo studies. J Neuroendocrinol 1993;5:51-61.
29. Lee S, Riviw C: Hypophysiotropic role and hypothalamic gene expression of corticotropin-releasing factor and vasopressin in rats injected with interleukin-1b systemically or into the brain ventricles. J Neuroendocrinol 1994;6:217-224.
30. De Simoni MG, del Bo R, de Luigi A, Simard S, Forloni G: Central endotoxin induces different patterns of interleukin-1 (IL)-1β and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology 1995;136: 897-902.
31. Lalé S, Bluthe R-M. Kent S, Combe C, Medina C, Pamet P, Kelley K, Dantzer R: Subdiaphragmatic vagotomy blocks induction of IL-1β mRNA in mouse brain in response to peripheral LPS. Am J Physiol 1995;268:R1327-R1331.
32. Turnbull AV: Mechanisms of activation of the pituitary-adrenal axis by tissue injury in the rat. Psychoneuroendocrinology 1994;19:165-178.
33. Navarra P: Interleukin-1β and interleukin-6 specifically increase the release of prostaglandin E2 from rat hypothalamic explants in vitro. Neuroendocrinology 1992;56:61-68.
34. Taylor AD, Loxley HD, Flower RJ, Buckingham JC: Immunoneutralization of lipocortin 1 reverses the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cqtokines in the rat in vitro and in vivo. Neuroendocrinology 1995;62:19-31.
35. Buckingham JC: Stress and the hypothalamo-pituitary-immune axis. Tissue Reactions 1997, in press.
36. Buckingham JC: Stress and the neuroendocrine-immune axis: The pivotal role of glucocorticoids and lipocortin 1. Br J Pharmacol 1996;118:1-19.
37. Ahluwalia A, Buckingham JC, Croxtall JD, Flower RJ, Goulding NJ, Perretti M: The biology of annexin 1; in Seaton BA (ed): Annexins: Molecular Structure to Cellular Function. Austin, Landes, 1996, pp 162-199.
38. Smith T, Flower RI, Buckingham JC: Lipocortins I, II and IV in the brain and pituitary gland: Selective induction of lipocortin I in the anterior pituitary gland. Mol Neuropharmacology 1993;3:45-55.
39. Philip JG, Flower RT, Buckingham JC: Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro. Neuro Report 1997;8,1871-1876.
40. Buckingham JC, Hedges JR: Production of corticotrophin releasing hormone by the isolated hypothalamus of the rat. J Physiol 1977;272: 469-479.
41. Hillhouse EW, Milton NGN: Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. J Endocrinol 1989;122:713-718.
42. Negro-Vilar A, Sanchez-Franco F, Kwaitkowski M, Samson WK: Failure to detect immunoassayable vasotocin in mammalian pineals. Brain Res Bull 1979;4:789-792.
43. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
44. Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrica 1965;52:591-611.
45. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB: Interleukins-1 and -6 stimulate the release of corticotrophin releasing hormone-41 from the rat hypothalamus via an eicosanoid-cyclooxygenase pathway. Endocrinology 1991;128:37-47.
46. Cowell A-M, Gillies GE, Buckingham JC: In vivo and in vitro methods for assessing the neuroendocrine function; in Buckingham JC, Cowell A-M, Gillies GE (eds): Stress, Stress Hormones and the Immune System, Chichester, Wiley, 1997, pp 129-156.
47. Clarke MJO, Gillies GE: Comparison of peptide release from fetal rat hypothalamic neurones cultured in defined media and serum containing media. J. Endocrinol 1988;116:349-356.
48. Emanuel RL: Developmental expression of conicotropin releasing hormone messenger RNA and peptide in rat hypothalamus. Peptides 1989; 10:1165-1169.
49. Chatelain A, Boudouresque F, Chautard T, Dupouy JP, Oliver C: Corticotropin releasing factor immunoreactivity in the hypothalamus of the rat during the perinatal period. J Endocrinol 1988; 119:59-64.
50. Rundle SE, Funder JW: Ontogeny of corticotropin-releasing factor and arginine vasopressin in the rat. Neuroendocrinology 1988;47:374-378.
51. Shanks N, La Rocque S, Meaney UT: Hypothalamic-pituitary-adrenal responses to endotoxin challenge in neonatal rats: Mediation via CRH. J Neuroendocrinol 1994;6:375-383.
52. Olpe H, McEwen BS: Glucocorticoid binding to receptor-like proteins in rat and pituitary: Ontogenetic and experimentally induced changes. Brain Res 1976;105:121-128.
53. Keller-Wood ME, Dallman MF: Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984; 5:1-24.
54. Bakker JM, Schmidt ED, Kraes H, Kavelaars A, Heijnen CT, Tilders FJH, van Rees EP: Effects of short-term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo-pituitary-adrenal axis in the rat. J Neuroimmunol 1995;63:183-191.
55. Bakker IM, Schmidt ED, Kraes H, Kavelaars A, Heijnen CT, Tilders FJH, van Rees EP: Effects of neonatal dexamethasone treatment on hypothalamo-pituitary adrenal axis and immune system of the rat. J Neuroimmunol 1997;74:69-76.
56. Sawchenko PE, Swanson LW: Organization of CRF: Immunoreactive cells and fibers in the rat brain: Immunocytochemical studies; in de Souza ER, Nemeroff CB (eds): Corticotrophin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. Boca Raton, CRC Press, 1990, pp 29-51.
57. Jingami H, Matsukura S, Numa S, Imura H: Effects of adrenalectomy and dexametasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/b-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 1985;117:1314-1320.
58. O'Donnell D, La Rocque S, Seckl JR, Meaney M: Postnatal handling alters glucocorticoid but not mineralocorticoid receptor mRNA expression in the hippocampus of adult rats. Mol Brain Res 1994;26:242-248.
59. McCormick CM, Smythe JW, Sharma S, Meaney MJ: Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Dev Brain Res 1995;84:55-61.
60. Levitt N, Lindsay RS, Holmes MC, Seckl JR: Prenatal dexamethasone programmes attenuated hippocampal glucoconicoid receptor gene expression and elevated basal corticosterone levels in adult life. 77th Am Endocr Soc Abstr 1995;No. 1-351, p 225.
61. Felszeghy K, Gáspár E, Nyakas C: Long-term selective down regulation of brain glucocorticoid receptors after neonatal dexamethasone treatment in rats. J Neuroendocrinol 1996;8:493-498.
62. Buckingham JC, Flower RJ: Lipocortin 1: A second messenger for the glucocorticoids in the hypothalamo-pituitary-adrenocortical axis. Mol Med Today 1997;3:296-302.